Comparative safety of antipsychotic medications in nursing home residents - Wikidata - awgldk - TriplyDB

Comparative safety of antipsychotic medications in nursing home residents

Comparative safety of antipsychotic medications in nursing home residents

http://www.wikidata.org/entity/Q35828059

about

'Big data' in mental health research: current status and emerging possibilities Fracture risk in long term care: a systematic review and meta-analysis of prospective observational studies Big data are coming to psychiatry: a general introduction Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.The explanatory role of stroke as a mediator of the mortality risk difference between older adults who initiate first- versus second-generation antipsychotic drugs Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Quetiapine safety in older adults: a systematic literature review.The Effects of Antipsychotic Quality Reporting on Antipsychotic and Psychoactive Medication Use.Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies.Mediators of First- Versus Second-generation Antipsychotic-related Mortality in Older Adults.Fracture risk in nursing home residents initiating antipsychotic medications.Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long-Acting β2 -Agonists and Inhaled Corticosteroids: The OUTPUL Study Pharmacogenetics of clinical response to risperidone.The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.Antipsychotic medication use in nursing homes: a proposed measure of quality.Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.Quality of psychopharmacological medication prescribing and mortality in Medicare beneficiaries in nursing homes.A comparison of risperidone and haloperidol for the risk of ischemic stroke in the elderly: a propensity score-matched cohort analysis.Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly.A qualitative study exploring visible components of organizational culture: what influences the use of psychotropic medicines in nursing homes?A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia.Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.Fall and Fracture Risk in Nursing Home Residents With Moderate-to-Severe Behavioral Symptoms of Alzheimer's Disease and Related Dementias Initiating Antidepressants or Antipsychotics.The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.Pharmacotherapy of Persons with Dementia in Long-Term Care in Australia: A Descriptive Audit of Central Nervous System Medications Rationales that providers and family members cited for the use of antipsychotic medications in nursing home residents with dementia.Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses.Effect of Bright Light Exposure on Depression and Agitation in Older Adults with Dementia.Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based cohort study in Denmark.Antipsychotic prescribing patterns, and the factors and outcomes associated with their use, among patients requiring prolonged mechanical ventilation in the long-term acute care hospital setting.Reducing Antipsychotic Medication Use in Nursing Homes: A Qualitative Study of Nursing Staff Perceptions.

P2860

Q26741297-E9E1EE98-054F-431F-9119-D729F5CB5098 Q26853714-47134C90-9B71-4D26-AB0D-4E21273A7D82 Q28602477-B3E067EB-6A98-4972-B633-E0887477AA4E Q34070862-0F7772F7-A189-4BAA-B6CF-2E5DB0C1DB3C Q34300560-09FED8C5-71CD-4EEB-92F9-28F601B0BF00 Q35502460-AFE1D082-2EC1-4903-947E-E8F837BF4C65 Q35754726-28BB5B19-27A9-4C96-815E-48CCEA0E6898 Q35905294-91339203-EE4B-4C75-AD10-F1BC6E1E2D54 Q35984041-FD1238DC-F54C-4E6B-B3B2-C2A24BD768C0 Q36405036-02CB4BD7-3B53-43BC-AC45-F9303E6E422D Q36482643-31A67CB2-EA38-4980-9171-4477B651CBE0 Q36849936-E5A6E494-025F-423F-B8DE-9C712B06B7CA Q37418094-A3FB79DE-B64B-40EF-9A1E-1453E11CA7D2 Q38074712-9087EAE9-8A57-476E-B38B-3129149A7157 Q38083586-167A042D-F36A-4F2C-B0E2-94E52BFD77E5 Q38197557-9DEF5A9C-0D4C-4A93-864C-A2AC2C4BCCD7 Q38214498-9E2CF586-A632-40C5-8C04-85E637F76DC6 Q38231604-1FBF873E-D2C2-4495-859F-916034CCD08A Q38397919-765665CF-3768-4D0F-B5B2-0302D9172871 Q38601671-5ABA4179-071E-41B1-A006-9A7C92B2BE21 Q38836769-E1E7FDD7-8E00-454F-8688-2EEE8E21338E Q38998448-77C8B112-01A7-4EE0-9930-7FBEDFA85DB2 Q39051107-2EA4F7BE-572A-4470-B5D4-5C815A2FD3FE Q39720028-DC04919B-C410-4A6B-9BD1-7C1704D876EA Q41170536-4ABDAA76-A4E9-474B-845E-9727035EC59B Q41248570-382234EB-094F-4B5E-A9E9-817C2096CA81 Q41492326-7D727273-2A3F-43F0-BDBF-B6095493BF2A Q44175464-EF93363B-C7D3-4AAC-B5C7-463D38B6A645 Q45035349-D1E135B8-7CE6-4B96-8FFB-0E8E77471146 Q50561711-C4830C5C-A3CA-41F7-94B6-3F056166B7DD Q51263674-C6571D5D-1BA7-4E94-B4C4-C1E011102050 Q51818301-7AEBFE13-B491-459C-8411-AC8A69154964

P2860

Comparative safety of antipsychotic medications in nursing home residents

http://www.wikidata.org/entity/Q35828059

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Comparative safety of antipsychotic medications in nursing home residents

@ast

Comparative safety of antipsychotic medications in nursing home residents

@en

type

label

Comparative safety of antipsychotic medications in nursing home residents

@ast

Comparative safety of antipsychotic medications in nursing home residents

@en

prefLabel

Comparative safety of antipsychotic medications in nursing home residents

@ast

Comparative safety of antipsychotic medications in nursing home residents

@en

P1433

Q35828059-B6262013-B580-4141-9848-770539F8B483

P1476

Q35828059-FEE4664A-668A-4FC5-833C-9EFB335F8E5A

P2093

Q35828059-003E00F3-3C2A-49C4-AD62-D2225DA09BA9

Q35828059-34BE4E26-7B24-409F-B55B-BA4B435F8212

Q35828059-417E9C34-8383-4FDA-B5ED-7EC8E35E656C

Q35828059-45813844-2FC7-45BB-9E04-494F67DC11C2

Q35828059-5BCD547A-97E6-40CC-8D1E-EEE712FF0DFC

Q35828059-E2003A45-F8C4-4630-9B0B-F1C360D5331F

Q35828059-EABA5792-EC26-4A0B-BC94-C95357CCE4E7

Q35828059-FF36BD4C-277C-400B-9C75-9B109DB91429

P2860

Q35828059-0C62AF9C-9609-4237-8315-E39F8679111F

Q35828059-127C101A-5CD0-4FF8-95C7-AB2C21774A26

Q35828059-311A44EE-10E4-4005-8AF2-1513BF774EEF

Q35828059-3380EAAB-6EB5-409A-AA9F-94EE62017974

Q35828059-386C7C21-000F-4F71-88C3-6DA1A0628876

Q35828059-4136E79D-AFDF-4EC5-AD92-3B84A4C5D12E

Q35828059-4A701B35-054A-48E1-9E23-E83D2D530C10

Q35828059-4B6F4D3B-898C-42E9-BB38-B5F3DB534B86

Q35828059-586291E4-3CD4-446A-ADEF-CB12754CBCFE

Q35828059-5D611307-0061-4F5E-8836-01A31DFB5C7D

P304

Q35828059-308BA47B-B9DC-41D6-8073-5C15BA35E393

P31

Q35828059-CF74A3DA-CE05-45CC-98E9-CBCBD4FA93B6

P356

Q35828059-70A7318A-B4FD-4187-B471-4C51845DE8C8

P407

Q35828059-E08800B9-C0DA-4DA1-ACAE-BC865605B2ED

P433

Q35828059-895845FB-D366-4FDE-9AA6-176A430B3566

P478

Q35828059-034F962B-302B-47D3-9867-3B7739147DCB

P577

Q35828059-D8EC22FD-675F-4E76-9C6F-B59CFA2CAA3E

P5875

Q35828059-A43CFEA9-5211-4DDA-B686-81EE888F8526

P698

Q35828059-075D7B37-BA49-4FA5-B276-A98C49703330

P932

Q35828059-10ECE32C-E729-432B-9297-16D8307470F6

P356

J.1532-5415.2011.03853.X

P1433

Journal of the American Geriatrics Society

P1476

Comparative safety of antipsychotic medications in nursing home residents

@en

P2093

Jerry Avorn

http://www.w3.org/2001/XMLSchema#string

Judith A Lucas

http://www.w3.org/2001/XMLSchema#string

Krista F Huybrechts

http://www.w3.org/2001/XMLSchema#string

Mark Olfson

http://www.w3.org/2001/XMLSchema#string

Raisa Levin

http://www.w3.org/2001/XMLSchema#string

Sebastian Schneeweiss

http://www.w3.org/2001/XMLSchema#string

Stephen Crystal

http://www.w3.org/2001/XMLSchema#string

Tobias Gerhard

http://www.w3.org/2001/XMLSchema#string

P2860

No adjustments are needed for multiple comparisons

The ongoing tyranny of statistical significance testing in biomedical research.

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

A basic study design for expedited safety signal evaluation based on electronic healthcare data.

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.

Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

P304

420-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1532-5415.2011.03853.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221827752

http://www.w3.org/2001/XMLSchema#string

P698

22329464

http://www.w3.org/2001/XMLSchema#string

P932

3302976

http://www.w3.org/2001/XMLSchema#string